erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
. in yarmouth two years ago sent five children home, causing young students at the very least to miss valuable school days.
.